For those that bought ACR before the testosterone troubles I can fully understand your bitterness. But for those that got in at a low price, the low price covers a lot of old sins. This is a turnaround situation, and as such carry’s more risk. I’ve been wondering why a testosterone partner , has not as yet been announced. So much work has already been done, as ACR said at the last AGM - FDA “approvals are imminent ”
Add to My Watchlist
What is My Watchlist?
